pamidronate has been researched along with Focal Segmental Glomerulosclerosis in 10 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The American Society of Clinical Oncology recommends bisphosphonate use, such as intravenous pamidronate, for women with breast cancer who have radiographic evidence of bone destruction." | 8.85 | Pamidronate-induced kidney injury in a patient with metastatic breast cancer. ( Nagahama, M; Sica, DA, 2009) |
| "Collapsing focal segmental glomerulosclerosis (cFSGS) is characterized by hyperplasia of glomerular epithelial cells." | 5.33 | Proliferating cells in HIV and pamidronate-associated collapsing focal segmental glomerulosclerosis are parietal epithelial cells. ( Assmann, KK; Dijkman, HB; Smeets, B; Steenbergen, EJ; van Kuppevelt, TH; Verrijp, KC; Weening, JJ; Wetzels, JF, 2006) |
| "Pamidronate, which is a member of the class of bisphosphonates, is widely used in the treatment of hypercalcemia of malignancy and osteolytic metastases." | 5.31 | Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate. ( Appel, GB; D'Agati, VD; Dratch, AD; Fenves, AZ; Fine, PL; Jagannath, S; Kuhn, JA; Loon, NR; Markowitz, GS, 2001) |
| "The American Society of Clinical Oncology recommends bisphosphonate use, such as intravenous pamidronate, for women with breast cancer who have radiographic evidence of bone destruction." | 4.85 | Pamidronate-induced kidney injury in a patient with metastatic breast cancer. ( Nagahama, M; Sica, DA, 2009) |
| "Pamidronate has been mainly associated with collapsing focal segmental glomerulosclerosis." | 3.72 | Podocyte injury associated glomerulopathies induced by pamidronate. ( Abulezz, SR; Barri, YM; Bonsib, SM; Munshi, NC; Sukumalchantra, S; Walker, PD; Wallach, J, 2004) |
| "Collapsing focal segmental glomerulosclerosis is well described in its idiopathic form, mostly seen in young African American patients, and in association with HIV virus." | 2.45 | [Bisphosphonate-induced collapsing focal segmental glomerulosclerosis; two clinical cases and literature review]. ( Jotterand, V; Martin, PY; Moll, S; Saudan, P, 2009) |
| " Patterns of nephrotoxicity described with these agents include toxic acute tubular necrosis and collapsing focal segmental glomerulosclerosis, respectively." | 2.44 | Bisphosphonate nephrotoxicity. ( Markowitz, GS; Perazella, MA, 2008) |
| "Collapsing focal segmental glomerulosclerosis (cFSGS) is characterized by hyperplasia of glomerular epithelial cells." | 1.33 | Proliferating cells in HIV and pamidronate-associated collapsing focal segmental glomerulosclerosis are parietal epithelial cells. ( Assmann, KK; Dijkman, HB; Smeets, B; Steenbergen, EJ; van Kuppevelt, TH; Verrijp, KC; Weening, JJ; Wetzels, JF, 2006) |
| "Pamidronate, which is a member of the class of bisphosphonates, is widely used in the treatment of hypercalcemia of malignancy and osteolytic metastases." | 1.31 | Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate. ( Appel, GB; D'Agati, VD; Dratch, AD; Fenves, AZ; Fine, PL; Jagannath, S; Kuhn, JA; Loon, NR; Markowitz, GS, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (90.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Perazella, MA | 1 |
| Markowitz, GS | 3 |
| Jotterand, V | 1 |
| Moll, S | 1 |
| Martin, PY | 1 |
| Saudan, P | 1 |
| Nagahama, M | 1 |
| Sica, DA | 1 |
| Yoshizawa, H | 1 |
| Akimoto, T | 1 |
| Nishino, K | 1 |
| Inoue, M | 1 |
| Ito, C | 1 |
| Takeda, S | 1 |
| Kotoda, A | 1 |
| Tamba, K | 1 |
| Yumura, W | 1 |
| Muto, S | 1 |
| Ueda, Y | 1 |
| Kusano, E | 1 |
| Barri, YM | 1 |
| Munshi, NC | 1 |
| Sukumalchantra, S | 1 |
| Abulezz, SR | 1 |
| Bonsib, SM | 1 |
| Wallach, J | 1 |
| Walker, PD | 1 |
| Kunin, M | 1 |
| Kopolovic, J | 1 |
| Avigdor, A | 1 |
| Holtzman, EJ | 1 |
| Nasr, SH | 1 |
| Preddie, DC | 1 |
| Appel, GB | 2 |
| D'Agati, VD | 2 |
| Sauter, M | 1 |
| Jülg, B | 1 |
| Porubsky, S | 1 |
| Cohen, C | 1 |
| Fischereder, M | 1 |
| Sitter, T | 1 |
| Schlondorff, D | 1 |
| Gröne, HJ | 1 |
| Dijkman, HB | 1 |
| Weening, JJ | 1 |
| Smeets, B | 1 |
| Verrijp, KC | 1 |
| van Kuppevelt, TH | 1 |
| Assmann, KK | 1 |
| Steenbergen, EJ | 1 |
| Wetzels, JF | 1 |
| Fine, PL | 1 |
| Fenves, AZ | 1 |
| Loon, NR | 1 |
| Jagannath, S | 1 |
| Kuhn, JA | 1 |
| Dratch, AD | 1 |
3 reviews available for pamidronate and Focal Segmental Glomerulosclerosis
| Article | Year |
|---|---|
Bisphosphonate nephrotoxicity.
Topics: Diphosphonates; Glomerulosclerosis, Focal Segmental; Humans; Imidazoles; Kidney Cortex Necrosis; Kid | 2008 |
[Bisphosphonate-induced collapsing focal segmental glomerulosclerosis; two clinical cases and literature review].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Diphosphonates; Female; Fractures, Spontaneous | 2009 |
Pamidronate-induced kidney injury in a patient with metastatic breast cancer.
Topics: Aged; Antineoplastic Agents; Apoptosis; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Female; Gl | 2009 |
7 other studies available for pamidronate and Focal Segmental Glomerulosclerosis
| Article | Year |
|---|---|
Nephrotic syndrome and renal failure in a patient with metastatic breast cancer.
Topics: Bone Neoplasms; Breast Neoplasms; Diphosphonates; Fatal Outcome; Female; Glomerulosclerosis, Focal S | 2011 |
Podocyte injury associated glomerulopathies induced by pamidronate.
Topics: Aged; Anti-Inflammatory Agents; Biopsy; Breast Neoplasms; Diphosphonates; Female; Glomerulosclerosis | 2004 |
Collapsing glomerulopathy induced by long-term treatment with standard-dose pamidronate in a myeloma patient.
Topics: Antineoplastic Agents; Basement Membrane; Diphosphonates; Female; Glomerulosclerosis, Focal Segmenta | 2004 |
Multiple myeloma, nephrotic syndrome and crystalloid inclusions in podocytes.
Topics: Acute Kidney Injury; Albumins; Bone Density Conservation Agents; Bone Diseases, Metabolic; Creatinin | 2006 |
Nephrotic-range proteinuria following pamidronate therapy in a patient with metastatic breast cancer: mitochondrial toxicity as a pathogenetic concept?
Topics: Antineoplastic Agents; Biopsy; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Diphosph | 2006 |
Proliferating cells in HIV and pamidronate-associated collapsing focal segmental glomerulosclerosis are parietal epithelial cells.
Topics: AIDS-Associated Nephropathy; Antineoplastic Agents; Biomarkers; Biopsy; Cell Division; Diphosphonate | 2006 |
Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate.
Topics: Aged; Antineoplastic Agents; Breast Neoplasms; Diphosphonates; Female; Glomerulosclerosis, Focal Seg | 2001 |